Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 16 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (5)
P 4 (1)

Trial Status

Completed8
Recruiting3
Not Yet Recruiting2
Unknown2
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 8 completed trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT07773636Not ApplicableNot Yet RecruitingPrimary

An Evaluation Study of Nursing Assistants' Performance of Electrocardiograms in Emergency Departments as Part of a Delegation of Medical Procedures

NCT07157449Recruiting

Identifying Electrocardiographic Markers to Determine Eligibility for the Implantation of a Subcutaneous Defibrillator.

NCT07533838Not ApplicableCompleted

The Effect of Simulation-Based ECG Training on ECG Reading Skills of Nursing Students

NCT07057440Not ApplicableCompleted

Effect of Nicotine Pouches on The Underlying Normal Electrocardiogram

NCT07254013Not ApplicableRecruiting

Left Bundle Branch Area Pacing (LBBAP) Monitoring Assistant: Evaluation of Portable ECG Solution

NCT07147920CompletedPrimary

Validation of Perin Health Patch ECG Monitoring Device Performance and Placement Accuracy

NCT07083791Not Yet Recruiting

AI-ECG Accessory Pathway Localisation Study

NCT06602635RecruitingPrimary

Hybrid Score to Predict OTVA-SOO in Patients with Wide Basal QRS

NCT06335498Completed

Further Study of AFGen1 Clinical Performance

NCT06076798Completed

Clinical Performance of AFGen1

NCT05591157Not ApplicableCompleted

Evaluation of CSF-3 in Performing ECG

NCT03727750Phase 4CompletedPrimary

Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML

NCT04885088Unknown

Smart Home Care of Cloud Base ECG on the Cardiotoxicity Prevention on the Cancer Patients.

NCT03715361CompletedPrimary

AF Stroke Substudy SL-ECG Versus 12lead ECG

NCT00730119Withdrawn

Evaluation Of The GE Monitor Product Line

NCT03206528Unknown

Clinical Evaluation of the Vital Signs Monitoring System (VSMS)

Showing all 16 trials

Research Network

Activity Timeline